Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven-Huy Han

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Gastroenterology|November 26, 2008
2-Year GLOBE trial results: telbivudine Is superior to lamivudine in patients with chronic hepatitis BYun-Fan Liaw, Edward Gane, Nancy Leung, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 8, 2025
Serum Proteomic Profile Based on the TGF-β Pathway Stratifies Risk of Hepatocellular CarcinomaXiyan Xiang, Kirti Shetty, Herbert Yu, et al.
Annals of Hepatology|October 15, 2016
Daclatasvir and Peginterferon/Ribavirin for Black/African-American and Latino Patients with HCV infectionMaribel Rodriguez-Torres, Eric Lawitz, Bienvenido Yangco, et al.
JHEP Reports : Innovation in Hepatology|March 21, 2024
Long-term open-label vebicorvir for chronic HBV infection: Safety and off-treatment responsesMan-Fung Yuen, Scott Fung, Xiaoli Ma, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Gastroenterology|November 26, 2008
2-Year GLOBE trial results: telbivudine Is superior to lamivudine in patients with chronic hepatitis BYun-Fan Liaw, Edward Gane, Nancy Leung, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 8, 2025
Serum Proteomic Profile Based on the TGF-β Pathway Stratifies Risk of Hepatocellular CarcinomaXiyan Xiang, Kirti Shetty, Herbert Yu, et al.
Annals of Hepatology|October 15, 2016
Daclatasvir and Peginterferon/Ribavirin for Black/African-American and Latino Patients with HCV infectionMaribel Rodriguez-Torres, Eric Lawitz, Bienvenido Yangco, et al.
JHEP Reports : Innovation in Hepatology|March 21, 2024
Long-term open-label vebicorvir for chronic HBV infection: Safety and off-treatment responsesMan-Fung Yuen, Scott Fung, Xiaoli Ma, et al.
Pageof 4